Sputnik pact with DRL sends Shilpa Medicare to 7-month high

The company entered into a three-year agreement with Dr Reddy’s for the production of Sputnik V vaccine for Covid-19. The targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production.

from Stocks-Markets-Economic Times https://ift.tt/3uYcCuH